Ness review

Ness’s semaglutide page (opens in a new tab) advertises a $150 first month with code YESNESS, followed by $250 monthly for all doses. Its tirzepatide page (opens in a new tab) shows $240 initially with the same code, then $340 monthly. The continuing price is the more useful baseline for an ongoing budget; the discounted first month does not repeat indefinitely.

The pages say there is no separate membership fee and include clinical review, a personalized plan, medication, supplies, shipping and ongoing support. Confirm the prescribed quantity and covered weeks rather than assuming that every delivery matches a calendar month. Our billing-cycle guide explains which dates and quantities to request.

The semaglutide page lists three months for $500 paid upfront, roughly $167 per month. Tirzepatide lists $680 upfront for three months, roughly $227 per month. Both offers explicitly require an existing Ness patient relationship or proof of a previous GLP-1 prescription. They should not be treated as universal starting prices for someone new to treatment.

The Ness FAQ (opens in a new tab) says existing patients can request a bundle after reaching a stable dose. If a clinician recommends a different medication or bundle, the team seeks approval before charging. Cancellation is described as refunding the balance minus medical reviews, with processed-prescription eligibility dependent on order status. Confirm the deduction, quantity supplied and unused-balance calculation before prepaying.

The medication FAQs identify CareValidate as a facilitating partner connecting patients with licensed clinicians and pharmacies. That is useful context, but it does not name the individual prescriber or dispensing facility for your own prescription. Ask for both, especially if a particular formulation or pharmacy matters to you.

Use our pharmacy verification checklist to check the assigned facility and its ability to dispense in your state. Ness’s footer limits purchases to adults in the United States, which is not a complete medication-by-state availability list. Compounded drugs are not FDA-approved; the clinical-trial figures discussed on the site do not establish outcomes for Ness’s particular compounded preparations.

Ness’s FAQ explicitly says it has no subscription and does not automatically charge the card each month. A GLP-1 check-in is required before each refill charge; the site describes a reminder fifteen days before the prescription period ends. If the clinician does not approve treatment, there is no charge. If approved but choosing not to continue, the patient owes a medical-review application fee whose amount is not stated.

The FAQ says shipped orders are not refundable and asks patients to request a refund within ten days of the original purchase or receipt. That request window does not override the shipped-order exclusion. For an order processed but not yet shipped, eligibility still depends on status. Obtain the applicable patient agreement, review-fee amount and cutoff before paying, and ask separately about damaged, incorrect or delayed deliveries.

Ness may suit readers who want dose-flat injection pricing and refills initiated through a check-in rather than automatic monthly billing. Compare the continuing rate with the restricted prepaid offer, including the risk of medical-review deductions or an order becoming nonrefundable. Confirm the actual prescriber, pharmacy and supplied weeks. Our lab-cost guide helps with testing costs that remain unclear. Oral and microdose programs require their own prescription and cost assessment.